ロード中...
Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells
The BRAF-MKK1/2-ERK1/2 pathway is constitutively activated in response to oncogenic mutations of BRAF in many cancer types, including melanoma. Although small molecules that inhibit oncogenic BRAF and MAP kinase kinase (MKK)1/2 have been successful in clinical settings, resistance invariably develop...
保存先:
| 出版年: | Mol Cell Proteomics |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Biochemistry and Molecular Biology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880111/ https://ncbi.nlm.nih.gov/pubmed/29255136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.RA117.000335 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|